Currently out of the existing stock ratings of Michael Sarcone, 6 are a HOLD (27.27%), 16 are a BUY (72.73%).
Analyst Michael Sarcone, currently employed at JEFFERIES, has had 80.21% of price targets met with an average potential upside of 15.77%, reached in 81 days on average.
Michael Sarcone has documented 44 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GKOS, Glaukos Corp at 21-Sep-2026.
Analyst best performing recommendations are on PROF.
The best stock recommendation documented was for EDAP on 4/4/2025. The price target of $2 was fulfilled within 21 days with a profit of $0.39 (24.22%), with a performance score of 11.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Aug-2026
$60
$4.07 (7.28%)
$53
20 days ago
(29-Oct-2026)
1/3 (33.33%)
$10.37 (20.89%)
41
Buy Since 19-Feb-2026
$56
$0.07 (0.13%)
$48
20 days ago
(29-Oct-2026)
3/3 (100%)
$6.37 (12.83%)
62
Buy Since 16-Oct-2023
$56
$0.07 (0.13%)
$25
20 days ago
(29-Oct-2026)
3/3 (100%)
$6.37 (12.83%)
126
Buy Since 30-Sep-2025
$56
$0.07 (0.13%)
$53
20 days ago
(29-Oct-2026)
6/6 (100%)
$6.37 (12.83%)
74
Buy Since 30-Oct-2018
$52
$-3.93 (-7.03%)
$19
1 months 6 days ago
(12-Oct-2026)
7/7 (100%)
$15.87 (43.92%)
1241
Which stock is Michael Sarcone most bullish on?
What Year was the first public recommendation made by Michael Sarcone?